FdaApplication
BLA 761310
Identifiers
- fda_app_no: BLA761310
Properties
| Property | Value |
|---|---|
| applicant_name | ImmunoGen, Inc. |
| application_type | BLA |
| approval_date | 2022-11-14 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ELAHERE | MIRVETUXIMAB SORAVTANSINE-GYNX | 100MG/20ML (5MG/ML) | Injection |
1 product